Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined platelet-enriched plasma and botulinum toxin injection for anal fissure
IRCT20251130068162N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of neuronox in anal fissure (2 arms), sponsored by Lorestan University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
neuronox
03
Conditions
anal fissure
Beyond the preview
Go deeper on IRCT20251130068162N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251130068162N1.